Antidepressant-like effect of lamotrigine is reversed by veratrine: A possible role of sodium channels in bipolar depression

Behavioural Brain Research

Volumn 191, Issue 1, 2008, Pages 49-54

  Prica, Corina ^a,b   Hascoet, Martine ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

Bipolar depression; Lamotrigine; Sodium channels; Veratrine

Indexed keywords

ANTIDEPRESSANT AGENT; CEVADINE; DESIPRAMINE; GLUTAMIC ACID; IMIPRAMINE; LAMOTRIGINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SODIUM CHANNEL; SODIUM CHANNEL STIMULATING AGENT; SODIUM CHLORIDE; TRICYCLIC ANTIDEPRESSANT AGENT; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIPOLAR DEPRESSION; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG MECHANISM; EPILEPSY; FORCED SWIMMING TEST; MALE; MEMBRANE STABILIZATION; MOUSE; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE DRUG DOSE; SODIUM CHANNELOPATHY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; IMMOBILITY RESPONSE, TONIC; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SWIMMING; TRIAZINES; VERATRINE;

EID: 43249122283     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.03.007     Document Type: Article

References (33)

1. Almeida R.C., Felisbino C.S., Lopez M.G., Rodrigues A.L.S., and Gabilan N.H. Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav Brain Res 168 (2006) 318-322
2. Bourin M., Masse F., and Hascoet M. Evidence for the activity of lamotrigine at 5-HT1A receptors in themouse forced swimming test. J PsychiatryNeurosci 30 (2005) 275-282
3. Bourin M., and Prica C. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders. Neurosci Biobehav Rev 31 6 (2007) 963-975
4. Bowden C.L., Mitchell P., and Suppes T. Lamotrigine in the treatment of bipolar depression. Eur Neuropsychopharmacol 4 (1999) S113-S117
5. + channels: local anaesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacol Sci 8 (1987) 57-65
6. + channels: an important target for anticonvulsant drugs. Adv Neurol 79 (1999) 441-456
7. Cheung H., Kamp D., and Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13 (1992) 107-112
8. Consoni F.T., Vital M.A., and Andreatini R. Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. Eur Neuropsychopharmacol 16 (2006) 451-458
9. Cunningham M.O., and Jones R.S.G. The anticonvulsivant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology 39 (2000) 2139-2146
10. Codagnone F.T., Consoni F.T., Rodrigues A.L., Vital M.A., and Andreatini R. Veratrine blocks the lamotrigine-induced swimming increase and immobility decrease in the modified forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 31 6 (2007) 1307-1311
11. Erfurth A., Walden J., and Grunze H. Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 38 (1998) 204-205
12. Ghaemi S.N., and Gaughan S. Novel anticonvulsants: a new generation of mood stabilizers. Harvard Rev Psychiatry 8 (2000) 1-7
13. Hodgkin A.L., and Huxley A.F. The components of membrane conductance in the giant axon of Loligo. J Physiol (Lond) 116 (1952) 473-496
14. Isom L.L., De Jongh K.S., and Catterall W.A. Auxiliary subunits of voltage-gated ion channels. Neuron 2 (1994) 1183-1194
15. + channel III deduced from the cDNA sequence. FEBS Lett 228 (1988) 187-194
16. Ketter T.A., Manji H.K., and Post R.M. Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol 23 (2003) 484-494
17. + channels. Mol Pharmacol 54 (1998) 712-721
18. + channels in rat hippocampal neurons. Br J Pharmacol 121 (1997) 1231-1238
19. Leach M.J., Marden C.M., and Miller A.A. Pharmacological studies of lamotrigine, a novel potential antipsychotic drug: neurochemical and clinical studies of the mechanism of action. Epilepsia 27 (1986) 490-497
20. Lingamaneni R., and Hemmings Jr. H.C. Effects of anticonvulsants on veratridineand KCl-evoked glutamate release from rat cortical synaptosomes. Neurosci Lett 276 2 (1999) 127-130
21. Lizasoain I., Knowles R.G., and Moncada S. Inhibition by lamotrigine of the generation of nitric oxide in rat forebrain slices. J Neurochem 64 2 (1995) 636-642
22. Meldrum B. Update on the mechanism of action of antiepileptic drugs. Epilepsia 37 (1996) S4-S11
23. Mirza N.R., Bright J.L., Stanhope K.J., and Wyatt A. Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels?. Psychopharmacology (Berlin) 180 (2005) 159-168
24. + channel messenger RNAs in rat brain. Nature 320 (1986) 188-192
25. Petit-Demouliere B., Chenu F., and Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berlin) 177 (2005) 245-255
26. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
27. Prakriya M., and Mennerick S. Selective depression of low-release probability excitatory synapses by sodium channel blockers. Neuron 26 (2000) 671-682
28. Redrobe J.P., Pinot P., and Bourin M. The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam Clin Pharmacol 10 (1996) 524-528
29. + channel expressed in neurons and glia. J Neurosci 15 (1995) 3231-3242
30. Southam E., Kirkby D., Higgins G.A., and Hagan R.M. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur J Pharmacol 358 (1998) 19-24
31. Suppes T., Brown S.E., McElroy L.S., Keck E.P., Nolen W., Kupka R., et al. Lamotrigine for the treatment of bipolar disorder: a clinical case series. J Affect Disorders 53 (1999) 95-98
32. Walden J., Hesslinger B.J., Van Calker D., and Berger M. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 29 (1996) 193-195
33. Waldmeier P.C., Martin P., Stocklin K., Portet C., and Schmutz M. Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn Schmiedebergs Arch Pharmacol 354 (1996) 164-172